NEW QUINAZOLINES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE - Patent 0639184

(19)

(11)

EP 0 639 184 A1

(12)

(43)	Date of publication:
	22.02.1995 Bulletin 1995/08

(21)	Application number: 93910860.0

(22)	Date of filing: 28.04.1993

(51)

International Patent Classification (IPC):

C07D 471/ 00^{( . )}
A61K 31/ 517^{( . )}
C07D 239/ 80^{( . )}
C07D 401/ 12^{( . )}
C07D 405/ 12^{( . )}

A61K 31/ 505^{( . )}
A61P 31/ 12^{( . )}
C07D 401/ 06^{( . )}
C07D 403/ 06^{( . )}

(86)	International application number:
	PCT/US1993/003975

(87)	International publication number:
	WO 1993/022292 (11.11.1993 Gazette 1993/27)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

07.05.1992 US 19920880119
16.12.1992 US 19920991164

(71)	Applicant: MERCK & CO. INC.
	Rahway New Jersey 07065-0900 (US)

(72)	Inventors:
	LYLE, Terry, A. Lederach, PA 19450 (US) TUCKER, Thomas, J. North Wales, PA 19454 (US) WISCOUNT, Catherine, M. Allentown, PA 18103 (US)

(74)	Representative: Thompson, John Dr.
	Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow, Essex CM20 2QR Harlow, Essex CM20 2QR (GB)

(54)	NEW QUINAZOLINES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE